PharmaRadar360

PharmaRadar360

🇨🇦·2d agoIndustry

Pr SILIQ ® (brodalumab injection) Now Reimbursed Under Alberta’s Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis

Publisher

B
Bausch Health (IR News)

Canada

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Bausch Health (IR News)
Region
Canada
Scope
Industry
Published
September 8, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on ir.bauschhealth.com

Leave the platform to read the original full article on the publisher site.

Source: Bausch Health (IR News)

Scope: Industry

Open original article
Pr SILIQ ® (brodalumab injection) Now Reimbursed Under Alberta’s Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis | PharmaRadar360